Your browser doesn't support javascript.
loading
Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag, Mette; Perner, Anders; Wetterslev, Jørn; Wise, Matt P; Borthwick, Mark; Bendel, Stepani; Pelosi, Paolo; Keus, Frederik; Guttormsen, Anne Berit; Schefold, Joerg C; Møller, Morten Hylander.
Afiliação
  • Krag M; Department of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. mette.krag.01@regionh.dk.
  • Perner A; Department of Intensive Care 4131 and Centre for Research in Intensive Care (CRIC), Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Wetterslev J; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Wise MP; Department of Adult Critical Care, University Hospital of Wales, Cardiff, UK.
  • Borthwick M; Pharmacy Department, Oxford University Hospitals NHS Trust, Oxford, UK.
  • Bendel S; Department of Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland.
  • Pelosi P; Department of Surgical Sciences and Integrated Diagnostics, IRCCS AOU San Martino IST, University of Genoa, Genoa, Italy.
  • Keus F; University of Groningen, Department of Critical Care, University Medical Center Groningen, Groningen, The Netherlands.
  • Guttormsen AB; Department of Anaesthesia and Intensive Care, Haukeland University Hospital and Clinical Institute 1 UiB, Bergen, Norway.
  • Schefold JC; Department of Intensive Care Medicine, University Hospital Inselspital, Bern, Switzerland.
  • Møller MH; Department of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Trials ; 17(1): 205, 2016 Apr 19.
Article em En | MEDLINE | ID: mdl-27093939

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Úlcera Péptica / Úlcera Péptica Hemorrágica / Inibidores da Bomba de Prótons / Antiulcerosos Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Trials Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Úlcera Péptica / Úlcera Péptica Hemorrágica / Inibidores da Bomba de Prótons / Antiulcerosos Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Trials Ano de publicação: 2016 Tipo de documento: Article